In metabolic therapies, the aim is to target diseased cells with appropriate radiopharmaceutical products. Radioactive atoms are administered to the patient via a carrier molecule having affinities with these cells. Once these molecules assimilated, the radioactive atom is found directly in contact with the cell. When it decays, the beta electron emitted deposits its energy by ionization inside it. The damage caused by ionizing radiation provokes its destruction.